← Back to Clinical Trials
Recruiting NCT06593925

NCT06593925 Polyoxymethylene (POM) in the Production of Telescopic Denture in Older Adults With Subtotal Edentulism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06593925
Status Recruiting
Phase
Sponsor University of Belgrade
Condition Subtotal Edentulism
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-01-30
Primary Completion 2024-12-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
Production of polyoxymethylene telescopic dentureProduction of conventional complex partial denture with clasps

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-01-30 with a primary completion date of 2024-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The mail goal of this study is to evaluate the success of the prosthetic treatment with telescopic removable partial denture with framework made of polyoxymethylene (POM). In accordance with the growing older population, who often require complex dental care, it is very important to test simple yet effective and safe solutions. Bearing in mind that POM has proven to be a good solution for conventional removable partial dentures with clasps (RPD), and that it is quite common to have 2-3 remaining teeth, a denture with a framework made of light and flexible material such as POM present a good solution. The hypothesis is that a POM telescopic denture is clinically as adequate, effective and safe as the conventional complex cobalt chromium molybdenum alloy denture with clasps. Telescopic denture should provide better comfort and longevity compared to conventional RPD because of axial loading of the abutment teeth and no negative biological effect of clasps. Moreover, conventional telescopic denture is made of precious alloys which increase their cost; therefore, POM telescopic denture present great advantage in cost/effective treatment. Telescopic crowns are comprised of inner and outer crowns; accordingly, telescopic denture represent a type of complex denture where one part is fixed on the remaining teeth (inner crowns) and other part (outer crowns and denture framework) is removable. The key factors that will define the success of the treatment will be: assessment of dentures' retention, oral health related quality of life, presence of biological complications, presence of mechanical complications, denture appearance and chewing function assessment.

Eligibility Criteria

Inclusion Criteria: * patients aged 65 and over * patients with subtotal edentulism * patients who sign an informed consent for participation in the study * retention teeth must have a minimum crown/root ratio of 1:1 * retention teeth must have sufficient tooth substance (at least two walls) Exclusion Criteria: * patients younger than 65 years * patients with temporomandibular joint dysfunction * patiens with bruxism * presence of intrabony defects around the retention teeth * presence of pathological tooth mobility * presence of periapical inflammatory processes, abscesses and fistulas in the region of retention teeth * presence of fetor and suppuration from periodontal pockets of retention teeth

Contact & Investigator

Central Contact

Djurdja Nedeljkovic

✉ dr.djurdja.nedeljkovic@gmail.com

📞 +381645105219

Principal Investigator

Aleksandra Popovac

STUDY CHAIR

School of Dental Medicine, University of Belgrade

Frequently Asked Questions

Who can join the NCT06593925 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Subtotal Edentulism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06593925 currently recruiting?

Yes, NCT06593925 is actively recruiting participants. Contact the research team at dr.djurdja.nedeljkovic@gmail.com for enrollment information.

Where is the NCT06593925 trial being conducted?

This trial is being conducted at Belgrade, Serbia.

Who is sponsoring the NCT06593925 clinical trial?

NCT06593925 is sponsored by University of Belgrade. The principal investigator is Aleksandra Popovac at School of Dental Medicine, University of Belgrade. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology